[go: up one dir, main page]

HK1198120A1 - 含有抗毒蕈碱剂和β-肾上腺素能激动剂的组合 - Google Patents

含有抗毒蕈碱剂和β-肾上腺素能激动剂的组合 Download PDF

Info

Publication number
HK1198120A1
HK1198120A1 HK14110614.9A HK14110614A HK1198120A1 HK 1198120 A1 HK1198120 A1 HK 1198120A1 HK 14110614 A HK14110614 A HK 14110614A HK 1198120 A1 HK1198120 A1 HK 1198120A1
Authority
HK
Hong Kong
Prior art keywords
agonist
antagonist
combination
muscarinic receptors
formoterol
Prior art date
Application number
HK14110614.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1198120B (zh
Inventor
Jordi Gras Escardo
Jesus Llenas Calvo
Hamish Ryder
Pio Orviz Diaz
Original Assignee
Almirall S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34956036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1198120(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall S.A. filed Critical Almirall S.A.
Publication of HK1198120A1 publication Critical patent/HK1198120A1/zh
Publication of HK1198120B publication Critical patent/HK1198120B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Wrappers (AREA)
HK14110614.9A 2004-05-31 2014-10-23 含有抗毒蕈碱剂和β-肾上腺素能激动剂的组合 HK1198120B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200401312A ES2257152B1 (es) 2004-05-31 2004-05-31 Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
ES200401312 2004-05-31

Publications (2)

Publication Number Publication Date
HK1198120A1 true HK1198120A1 (zh) 2015-03-13
HK1198120B HK1198120B (zh) 2015-09-11

Family

ID=

Also Published As

Publication number Publication date
ME01680B (me) 2010-08-31
HUP0600139A2 (en) 2007-06-28
JP4928258B2 (ja) 2012-05-09
ATE424847T1 (de) 2009-03-15
BRPI0511666A (pt) 2008-01-02
IL179687A (en) 2011-11-30
CY1109938T1 (el) 2014-09-10
JP2012184272A (ja) 2012-09-27
US20140094442A1 (en) 2014-04-03
US20150080359A1 (en) 2015-03-19
US20110021477A1 (en) 2011-01-27
PT2292267E (pt) 2014-10-15
AU2005247103B2 (en) 2010-10-28
US20100048616A1 (en) 2010-02-25
JP5049120B2 (ja) 2012-10-17
AU2005247107B2 (en) 2010-10-28
US20120059031A1 (en) 2012-03-08
SI21784A (sl) 2005-12-31
US20120309726A1 (en) 2012-12-06
IL179687A0 (en) 2007-05-15
US20100048615A1 (en) 2010-02-25
ES2293849A1 (es) 2008-03-16
UA89182C2 (ru) 2010-01-11
EP1765404A1 (en) 2007-03-28
KR20130027586A (ko) 2013-03-15
US20160038470A1 (en) 2016-02-11
US20050267078A1 (en) 2005-12-01
FR2870744B1 (fr) 2006-12-08
CA2533061C (en) 2008-07-08
HRP20090215T1 (hr) 2009-05-31
BRPI0511669A (pt) 2008-01-02
MXPA06013847A (es) 2007-03-01
US20090093503A1 (en) 2009-04-09
CY1110798T1 (el) 2015-06-10
EP1763369A1 (en) 2007-03-21
CY2015006I1 (el) 2016-06-22
WO2005115466A8 (en) 2007-01-04
US20090111785A1 (en) 2009-04-30
ZA200609987B (en) 2007-12-27
IL179689A0 (en) 2007-05-15
JP2012012407A (ja) 2012-01-19
HRP20100489T1 (hr) 2010-10-31
EP2319538A2 (en) 2011-05-11
ITMI20051021A1 (it) 2005-12-01
RS51386B (sr) 2011-02-28
CH696962A5 (fr) 2008-02-29
NO20065477L (no) 2006-12-22
CA2568566A1 (en) 2005-12-08
DE602005011803D1 (de) 2009-01-29
ES2322280T3 (es) 2009-06-18
JP5133054B2 (ja) 2013-01-30
NO20065478L (no) 2006-12-28
US20100056486A1 (en) 2010-03-04
EP2138188A1 (en) 2009-12-30
RU2006147268A (ru) 2008-07-20
ES2505329T3 (es) 2014-10-09
US20060154934A1 (en) 2006-07-13
CN1960761A (zh) 2007-05-09
UA89184C2 (ru) 2010-01-11
US20120309727A1 (en) 2012-12-06
UA89181C2 (ru) 2010-01-11
US20120071452A1 (en) 2012-03-22
CN102755321B (zh) 2015-07-15
ZA200600261B (en) 2007-04-25
RU2006147250A (ru) 2008-07-20
MC200083A1 (fr) 2005-12-07
GB0526502D0 (en) 2006-02-08
HK1095757A1 (zh) 2007-05-18
US20130252928A1 (en) 2013-09-26
US20120302532A1 (en) 2012-11-29
JP2006527183A (ja) 2006-11-30
ZA200609985B (en) 2008-09-25
NO20065476L (no) 2006-12-28
WO2005115466A1 (en) 2005-12-08
US20110021478A1 (en) 2011-01-27
JP5032984B2 (ja) 2012-09-26
ES2348558T3 (es) 2010-12-09
ES2348680T3 (es) 2010-12-10
RU2010129940A (ru) 2012-01-27
WO2005115462A1 (en) 2005-12-08
US20120040943A1 (en) 2012-02-16
EP1763368B1 (en) 2009-03-11
IE20050366A1 (en) 2005-11-30
HUP0600139A3 (en) 2010-12-28
JP5538485B2 (ja) 2014-07-02
PL1763368T5 (pl) 2014-01-31
BRPI0511660A (pt) 2008-01-02
CA2569077C (en) 2012-12-18
CY1108885T1 (el) 2014-07-02
WO2005115467A1 (en) 2005-12-08
HK1125573A1 (zh) 2009-08-14
EP2002845A2 (en) 2008-12-17
IL179684A (en) 2011-11-30
RU2465902C2 (ru) 2012-11-10
ES2257152A1 (es) 2006-07-16
EP2292267B1 (en) 2014-07-23
KR20070018105A (ko) 2007-02-13
CL2011000607A1 (es) 2011-08-19
ES2318498T3 (es) 2009-05-01
LU91214B1 (fr) 2006-01-26
RS50717B (sr) 2010-06-30
US20110021476A1 (en) 2011-01-27
TWI404530B (zh) 2013-08-11
EP1891973B1 (en) 2010-07-21
DK1763368T4 (da) 2013-11-04
DK1763369T3 (da) 2009-03-16
US20150306079A1 (en) 2015-10-29
CA2569077A1 (en) 2005-12-08
NO20065479L (no) 2006-12-22
ZA200609989B (en) 2007-11-28
ME02134B (me) 2015-02-27
US20050288266A1 (en) 2005-12-29
US20080051378A1 (en) 2008-02-28
EP1763368A1 (en) 2007-03-21
NL1029151A1 (nl) 2005-12-05
ES2257152B1 (es) 2007-07-01
EP2292267A2 (en) 2011-03-09
BRPI0511656A (pt) 2008-01-02
PT1891973E (pt) 2010-09-27
BRPI0511667A (pt) 2008-01-02
DK1891973T3 (da) 2010-10-18
NO20065483L (no) 2006-12-22
ZA200609990B (en) 2007-12-27
AU2005247108A1 (en) 2005-12-08
EP1891973A1 (en) 2008-02-27
NO20065482L (no) 2006-12-22
DE602005022497D1 (de) 2010-09-02
KR101256417B1 (ko) 2013-04-22
PL1765404T3 (pl) 2009-06-30
ECSP067038A (es) 2006-12-29
DK1763368T3 (da) 2009-05-04
ME02779B (me) 2010-06-30
NZ551668A (en) 2010-06-25
RS50787B (sr) 2010-08-31
RU2373935C2 (ru) 2009-11-27
CN102085373A (zh) 2011-06-08
EP2002845A3 (en) 2009-02-25
SI1891973T1 (sl) 2010-11-30
PE20060292A1 (es) 2006-04-14
NL300720I1 (zh) 2016-01-07
CN101018566A (zh) 2007-08-15
ES2293849B2 (es) 2009-04-16
JP5107701B2 (ja) 2012-12-26
CN1960759A (zh) 2007-05-09
GB2419819A (en) 2006-05-10
HRP20140864T1 (hr) 2014-12-05
SI1763368T2 (sl) 2013-12-31
US20080045565A1 (en) 2008-02-21
BE1016608A5 (fr) 2007-02-06
US20090099148A1 (en) 2009-04-16
NO334337B1 (no) 2014-02-10
RU2404771C3 (ru) 2018-03-12
NL300720I2 (zh) 2016-01-07
NO2015007I1 (no) 2015-03-09
EP2002844B1 (en) 2010-12-29
CY1109139T1 (el) 2014-07-02
DK2292267T3 (da) 2014-09-15
EP1763369B1 (en) 2008-12-17
US20200009117A1 (en) 2020-01-09
HUS1500011I1 (hu) 2018-09-28
ZA200609986B (en) 2007-11-28
JP2008500988A (ja) 2008-01-17
JP2008500987A (ja) 2008-01-17
ECSP067037A (es) 2006-12-29
MY142095A (en) 2010-09-15
EP2002843A3 (en) 2009-04-08
BRPI0511662B1 (pt) 2019-02-19
GR1006045B (el) 2008-09-08
EP2774622A1 (en) 2014-09-10
ATE474600T1 (de) 2010-08-15
US20130310354A1 (en) 2013-11-21
PT1763369E (pt) 2009-02-26
EP2210613A1 (en) 2010-07-28
KR20070024556A (ko) 2007-03-02
GR20050100269A (el) 2005-12-31
EP2002844A2 (en) 2008-12-17
CA2533061A1 (en) 2005-12-08
EP2774623A1 (en) 2014-09-10
AR049066A1 (es) 2006-06-21
DK1765404T3 (da) 2009-03-16
RS50787B2 (sr) 2018-02-28
US20070167489A1 (en) 2007-07-19
ECSP067035A (es) 2006-12-29
AU2005247103A1 (en) 2005-12-08
US20070232637A1 (en) 2007-10-04
CN1960762A (zh) 2007-05-09
JP2008500989A (ja) 2008-01-17
PL379660A1 (pl) 2006-11-13
ME01670B (me) 2010-06-30
BRPI0511662B8 (pt) 2021-05-25
EP2002844A3 (en) 2009-03-04
PL1891973T3 (pl) 2010-11-30
ECSP067033A (es) 2006-12-29
NO2015007I2 (no) 2015-12-21
SI1763369T1 (sl) 2009-06-30
CA2568566C (en) 2012-12-18
CN1960760A (zh) 2007-05-09
TW200608971A (en) 2006-03-16
EP2292267A3 (en) 2011-06-15
HRP20090215T4 (hr) 2013-12-20
FR15C0017I2 (fr) 2015-11-13
CY1115669T1 (el) 2017-01-25
CN102755321A (zh) 2012-10-31
EP2002843A2 (en) 2008-12-17
PE20081650A1 (es) 2008-12-06
CY2015006I2 (el) 2016-06-22
PE20081649A1 (es) 2008-11-28
BRPI0511662A (pt) 2008-01-02
RU2006142331A (ru) 2008-06-20
ES2322280T5 (es) 2013-12-03
US20180200234A1 (en) 2018-07-19
FR15C0017I1 (zh) 2015-03-04
US20140296197A1 (en) 2014-10-02
US20060205702A1 (en) 2006-09-14
AU2005247108B2 (en) 2008-09-11
JP2008500990A (ja) 2008-01-17
JP4966192B2 (ja) 2012-07-04
UA86976C2 (ru) 2009-06-10
US20090176751A1 (en) 2009-07-09
IL179689A (en) 2012-02-29
IL179684A0 (en) 2007-05-15
HK1090306A1 (zh) 2006-12-22
US20130035319A1 (en) 2013-02-07
NL1029151C2 (nl) 2006-06-22
US20050267135A1 (en) 2005-12-01
RS53529B1 (sr) 2015-02-27
ATE417627T1 (de) 2009-01-15
SI1763368T1 (sl) 2009-08-31
UA89185C2 (ru) 2010-01-11
RU2385721C2 (ru) 2010-04-10
US20170049756A1 (en) 2017-02-23
PT1763368E (pt) 2009-05-14
LTC1763368I2 (lt) 2016-12-27
EP1765404B1 (en) 2008-12-31
MXPA06004124A (es) 2006-06-27
US20140148420A1 (en) 2014-05-29
NO338621B1 (no) 2016-09-19
FR2870744A1 (fr) 2005-12-02
KR101174677B1 (ko) 2012-08-17
PL1763368T3 (pl) 2009-08-31
EP1761280A1 (en) 2007-03-14
PL2292267T3 (pl) 2015-03-31
ECSP067036A (es) 2006-12-29
NZ544539A (en) 2007-09-28
US20080146603A1 (en) 2008-06-19
RU2404771C2 (ru) 2010-11-27
PL1763369T3 (pl) 2009-06-30
US20120088743A1 (en) 2012-04-12
UY28933A1 (es) 2005-08-31
MXPA06013848A (es) 2007-03-01
EP2774622B1 (en) 2015-03-11
GB2419819B (en) 2007-02-21
HRP20090107T3 (en) 2009-03-31
UA89183C2 (ru) 2010-01-11
US20150202213A1 (en) 2015-07-23
EP2774623B1 (en) 2015-04-08
US20060189651A1 (en) 2006-08-24
EP1763368B2 (en) 2013-08-21
NZ551667A (en) 2010-07-30
CN1972716A (zh) 2007-05-30
CN1960759B (zh) 2011-07-13
EP2319538A3 (en) 2011-06-15
DE602005013220D1 (de) 2009-04-23
SI2292267T1 (sl) 2014-11-28
AU2005247107A1 (en) 2005-12-08
CY1108902T1 (el) 2014-07-02
JP2008500986A (ja) 2008-01-17
ECSP067034A (es) 2006-12-29

Similar Documents

Publication Publication Date Title
EP2774623B1 (en) Combinations comprising antimuscarinic agents and beta-adrenergic agonists
AU2005247104B2 (en) Combinations comprising antimuscarinic agents and beta-adrenergic agonists
HK1198120B (zh) 含有抗毒蕈碱剂和β-肾上腺素能激动剂的组合
HK1125573B (zh) 含有抗毒蕈硷剂和β-肾上腺素受体激动剂的结合物
HK1096605B (zh) 包含抗毒蕈碱剂和β-肾上腺素能激动剂的组合
HK1095757B (zh) 包含抗毒蕈碱剂和皮质甾类的组合
HK1109871B (zh) 包含抗毒蕈碱剂和皮质甾类的组合
HK1109871A1 (zh) 包含抗毒蕈碱剂和皮质甾类的组合

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20250530